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Collision of communicable and non-communicable disease 
epidemics—the case of HIV and COPD
In this issue of The Lancet Global Health, Jean Joel Bigna 
and colleagues report the results of their systematic 
review and meta-analysis of studies of chronic 
obstructive pulmonary disease (COPD) in people 
with HIV.1 COPD is one of the most common non-
communicable diseases that, as a group, are the leading 
causes of morbidity and mortality worldwide.2 HIV is 
one of the principal infectious causes for morbidity and 
mortality globally.3 Although typically thought of as a 
problem of high-income countries, most of the burden 
of non-communicable diseases is seen in low-income 
and middle-income countries (LMICs), where they 
drive and perpetuate poverty.4 It is also in LMICs—and 
especially LMICs in the continent of Africa—where the 
greatest global burden of HIV is seen. As such, this first 
systematic review and meta-analysis of COPD in people 
with HIV is very timely.
Bigna and colleagues identified 30 observational 
studies involving 151 686 participants, which reported 
estimates of the prevalence of COPD in the HIV-infected 
population between 5·6% and 10·6%.1 Meta-analysis of 
data from these studies showed a higher risk of COPD in 
people living with HIV, versus those without HIV (pooled 
odds ratio 1·14, 95% CI 1·05–1·25).
Although most of the included studies were done in 
high-income countries in Europe and North America, 
most of the people with COPD and HIV live in LMICs. 
Only four of the included studies were done in Africa, 
the WHO region with the most people living with 
HIV.3 This finding is similar to what we found in 2013, 
when we did a systematic review of COPD studies in 
sub-Saharan Africa and found only one high quality 
prevalence study. This Burden of Obstructive Lung 
Disease (BOLD) study was done in South Africa and 
found a high prevalence of COPD: 22% of men and 
17% of women.5,6 Taken together, these observations 
highlight an important imbalance between where 
this kind of research is done and where the need is 
greatest.
As Bigna and colleagues note, prevalence estimates 
vary depending on the diagnostic criteria used. 
Although most of the included studies used spirometry-
defined COPD, many did not, raising the possibility that 
some of the studies included people without COPD. 
This is another issue that is particularly relevant to 
Africa, where access to quality-assured spirometry is 
limited,7,8 and where results from recent BOLD studies 
have suggested that the most prominent problem is 
a high prevalence of low lung volume (low forced vital 
capacity), and not airflow obstruction.9
One of these studies was a non-communicable lung 
disease study (incorporating a BOLD study) that we 
did in urban Blantyre, Malawi, in which 24% of study 
participants had HIV. We found that more than 40% of 
the participants had abnormal lung function—mostly 
low forced vital capacity—but with no association 
between spirometric abnormalities and HIV.10
It is clear that we need a better understanding of the 
epidemiology of non-communicable lung diseases, 
including COPD, in African and other LMICs where 
the communicable and non-communicable disease 
epidemics and their various and overlapping risk factors 
collide. Although there is no doubt that tackling the 
tobacco epidemic is the greatest priority for COPD 
prevention and control globally, irrespective of other 
risk factors, there are parts of the world (including 
Africa) where other risk factors, such as HIV, are also of 
great relevance. It is not known how the natural course 
of COPD might differ in people with and without HIV, 
or whether there would be differences in the approach 
to the airways disease management between the two 
groups. The Article by Bigna and colleagues sets the 
scene for this work to be done, and we suggest that this 
should be focused on the region of the world that needs 
it most—Africa.
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